Compare MOV & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOV | BVS |
|---|---|---|
| Founded | 1961 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.7M | 482.9M |
| IPO Year | N/A | 2016 |
| Metric | MOV | BVS |
|---|---|---|
| Price | $25.63 | $8.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $31.50 | $13.33 |
| AVG Volume (30 Days) | 128.0K | ★ 232.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.62% | N/A |
| EPS Growth | N/A | ★ 79.12 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $573,280,000.00 |
| Revenue This Year | $2.30 | N/A |
| Revenue Next Year | $1.17 | $6.78 |
| P/E Ratio | ★ $25.52 | $71.50 |
| Revenue Growth | N/A | ★ 11.89 |
| 52 Week Low | $12.85 | $5.81 |
| 52 Week High | $25.85 | $11.25 |
| Indicator | MOV | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 63.05 | 58.54 |
| Support Level | $24.38 | $8.30 |
| Resistance Level | $25.18 | $8.64 |
| Average True Range (ATR) | 0.80 | 0.39 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 83.33 | 51.60 |
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.